Clinical Trial Update: Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung Diseases [Phase 1]

View source ↗

Summary

Phase 1 study assessing lung deposition, pharmacokinetics, safety, and tolerability of single inhalations of radiolabeled ciprofloxacin dry powder in healthy su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Disease

Drugs mentioned

• ciprofloxacin dry powder inhalation (ciprofloxacin)

Snippet

Sponsor: Bayer | Conditions: Respiratory System | Phase 1 | Status: COMPLETED